Familial MTC (FMTC) harbors mutations similar to MEN2A, involving either the extracellular or the intracellular domain of the tyrosine kinase receptor; it is now considered an MEN2A variant. This evidence concerns the gene RET and medullary thyroid gland carcinoma.